Drug Discovery · Cambridge, MA · Founded 2019 · In IPO Registration
Developer of prophylactic therapeutics designed for bleeding and thrombosis disorders. Hemab Therapeutics Holdings is based in Cambridge, MA and was founded in 2019. It is valued at about $387 million as of Oct 2026, set by institutional fund marks. It has raised $355 million across 2 recorded rounds; the latest was a $157 million Series C in Oct 2025.
PMV mark · valuation
$386.9M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$355.1M
Last round
Later Stage VC (Series C)
Oct 2025
Team — not yet on record
No current team members for Hemab Therapeutics Holdings are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hemab Therapeutics Holdings with a free account
·The complete investor list: 12 names
·Watch Hemab Therapeutics Holdings: the Monday email on marks, rounds and moves
